Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Mark J Alles. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Mark J Alles zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:SYRS / Syros Pharmaceuticals, Inc. | Director | 3 666 |
| US:BMRN / BioMarin Pharmaceutical Inc. | Director | 15 095 |
| US:TPTX / Turning Point Therapeutics Inc | Director | 0 |
| US:CELG / Celgene Corp. | CEO, CHAIRMAN OF BOARD, Director | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Mark J Alles. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera SYRS / Syros Pharmaceuticals, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w SYRS / Syros Pharmaceuticals, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-05-13 | SYRS | Alles Mark J | 10 000 | 8,8590 | 1 000 | 88,5900 | 88 590 | 251 | 149.5 | 60 910 | 68,75 |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera SYRS / Syros Pharmaceuticals, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w SYRS / Syros Pharmaceuticals, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do min |
Cena min |
Uniknięta maksymalna strata ($) |
Uniknięta Maksymalna strata (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Mark J Alles ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-19 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 2 666 | 3 666 | 266,60 | ||||
| 2023-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 190 | 15 095 | 38,42 | ||||
| 2022-11-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 3 625 | 10 905 | 49,79 | 86,75 | 314 469 | 946 009 | |
| 2022-08-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -2 000 | 0 | -100,00 | 76,00 | -152 000 | ||
| 2022-05-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 980 | 7 280 | 216,52 | ||||
| 2022-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 2 300 | 2 300 | |||||
| 2021-06-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
P - Purchase | 2 000 | 2 000 | 81,34 | 162 680 | 162 680 | ||
| 2021-06-10 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
| 2021-06-04 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
A - Award | 209 | 209 | |||||
| 2021-05-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
A - Award | 17 000 | 17 000 | |||||
| 2020-06-11 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
| 2020-05-13 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Common Stock |
P - Purchase | 10 000 | 10 000 | 8,86 | 88 590 | 88 590 | ||
| 2019-12-20 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 35 000 | 35 000 | |||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -29 669 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -29 669 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -8 625 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -8 625 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -8 625 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -8 625 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10 175 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10 175 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -15 670 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -20 350 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -17 738 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -17 738 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -19 688 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -17 738 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -17 738 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -12 488 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -17 500 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -8 326 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -8 326 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -8 326 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10 994 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -6 252 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -366 495 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 74 414 | 366 495 | 25,48 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 45 119 | 292 081 | 18,27 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 25 696 | 246 962 | 11,61 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -115 755 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted stock Unit |
D - Sale to Issuer | -18 800 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -30 079 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -17 131 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -59 234 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -59 234 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -59 234 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -33 881 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -33 881 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -33 881 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -33 880 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -29 669 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -29 669 | 0 | -100,00 | ||||
| 2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -15 608 | 0 | -100,00 | ||||
| 2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -6 620 | 221 266 | -2,90 | 95,21 | -630 290 | 21 066 736 | |
| 2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 15 608 | 227 886 | 7,35 | ||||
| 2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
M - Exercise | -33 809 | 0 | -100,00 | ||||
| 2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 115 755 | 115 755 | |||||
| 2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -13 900 | 212 278 | -6,15 | 85,96 | -1 194 844 | 18 247 417 | |
| 2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 33 809 | 226 178 | 17,58 | ||||
| 2019-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 18 800 | 18 800 | |||||
| 2019-01-30 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
A - Award | 33 809 | 33 809 | |||||
| 2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -8 929 | 0 | -100,00 | ||||
| 2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -3 876 | 192 369 | -1,98 | 68,20 | -264 343 | 13 119 566 | |
| 2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 8 929 | 196 245 | 4,77 | ||||
| 2018-10-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 59 234 | 59 234 | |||||
| 2018-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 59 234 | 59 234 | |||||
| 2018-05-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 1 208 | 187 316 | 0,65 | 82,60 | 99 784 | 15 472 864 | |
| 2018-05-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 30 079 | 30 079 | |||||
| 2018-05-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (Right to Buy) |
A - Award | 59 234 | 59 234 | |||||
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -3 500 | 0 | -100,00 | ||||
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -1 519 | 186 108 | -0,81 | 86,89 | -131 986 | 16 170 924 | |
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 500 | 187 627 | 1,90 | ||||
| 2018-02-20 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
M - Exercise | -7 283 | 0 | -100,00 | ||||
| 2018-02-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -2 060 | 184 127 | -1,11 | 95,26 | -196 236 | 17 539 938 | |
| 2018-02-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 283 | 186 187 | 4,07 | ||||
| 2018-02-15 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
A - Award | 7 283 | 7 283 | |||||
| 2018-02-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 3 260 | 178 904 | 1,86 | 91,90 | 299 594 | 16 441 278 | |
| 2018-01-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 33 881 | 33 881 | |||||
| 2017-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -4 550 | 0 | -100,00 | ||||
| 2017-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -2 094 | 175 644 | -1,18 | 107,06 | -224 184 | 18 804 447 | |
| 2017-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 550 | 177 738 | 2,63 | ||||
| 2017-10-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 33 881 | 33 881 | |||||
| 2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 33 881 | 33 881 | |||||
| 2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -4 200 | 0 | -100,00 | ||||
| 2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -1 932 | 173 188 | -1,10 | 134,10 | -259 081 | 23 224 511 | |
| 2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 200 | 175 120 | 2,46 | ||||
| 2017-05-02 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 17 131 | 17 131 | |||||
| 2017-05-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 33 880 | 33 880 | |||||
| 2017-02-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -6 643 | 170 920 | -3,74 | 117,02 | -777 364 | 20 001 058 | |
| 2017-02-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 14 447 | 177 563 | 8,86 | ||||
| 2017-01-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 29 669 | 29 669 | |||||
| 2016-12-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -6 560 | 0 | -100,00 | ||||
| 2016-12-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -3 018 | 163 116 | -1,82 | 117,63 | -355 007 | 19 187 335 | |
| 2016-12-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 560 | 166 134 | 4,11 | ||||
| 2016-11-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 29 669 | 29 669 | |||||
| 2016-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 29 669 | 29 669 | |||||
| 2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 15 608 | 15 608 | |||||
| 2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 29 669 | 29 669 | |||||
| 2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -11 000 | 0 | -100,00 | ||||
| 2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -5 062 | 159 574 | -3,07 | 103,41 | -523 461 | 16 501 547 | |
| 2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 11 000 | 164 636 | 7,16 | ||||
| 2016-02-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -11 889 | 153 636 | -7,18 | 102,45 | -1 218 028 | 15 740 008 | |
| 2016-02-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 25 840 | 165 525 | 18,50 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 506 | 2 704 | -35,77 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 720 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 128 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 292 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 926 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 500 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 266 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 438 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 528 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 634 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 506 | 139 685 | 1,09 | 36,96 | 55 662 | 5 162 758 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 720 | 138 179 | 1,26 | 25,76 | 44 316 | 3 560 182 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 128 | 136 459 | 0,83 | 30,74 | 34 675 | 4 194 750 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 292 | 135 331 | 1,72 | 28,50 | 65 311 | 3 856 257 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 926 | 133 039 | 1,47 | 19,24 | 37 047 | 2 559 005 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 500 | 131 113 | 1,94 | 25,18 | 62 950 | 3 301 425 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 266 | 128 613 | 0,99 | 31,21 | 39 512 | 4 014 012 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 438 | 127 347 | 1,95 | 24,80 | 60 475 | 3 158 842 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 528 | 124 909 | 3,76 | 29,02 | 131 403 | 3 624 859 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 634 | 120 381 | 2,24 | 27,42 | 72 237 | 3 301 449 | |
| 2015-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -11 670 | 11 670 | -50,00 | ||||
| 2015-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -5 370 | 117 747 | -4,36 | 112,17 | -602 353 | 13 207 681 | |
| 2015-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 11 670 | 123 117 | 10,47 | ||||
| 2015-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 8 929 | 8 929 | |||||
| 2015-11-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
| 2015-07-29 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
| 2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3 500 | 3 500 | |||||
| 2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
| 2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -11 200 | 0 | -100,00 | ||||
| 2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -5 154 | 111 447 | -4,42 | 108,06 | -556 941 | 12 042 963 | |
| 2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 11 200 | 116 601 | 10,63 | ||||
| 2015-03-03 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -8 334 | 0 | -100,00 | ||||
| 2015-03-03 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -4 078 | 105 401 | -3,72 | 121,53 | -495 599 | 12 809 384 | |
| 2015-03-03 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 8 334 | 109 479 | 8,24 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 640 | 13 124 | -11,11 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 478 | 11 824 | -11,11 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 478 | 11 824 | -11,11 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 478 | 11 824 | -11,11 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 478 | 17 738 | -7,69 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 040 | 10 468 | -9,04 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 040 | 10 468 | -9,04 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 375 | 17 500 | -20,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 081 | 8 326 | -20,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 081 | 8 326 | -20,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 562 | 8 290 | -15,85 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -430 | 0 | -100,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -430 | 0 | -100,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5 333 | 0 | -100,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -860 | 0 | -100,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -148 | 0 | -100,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -573 | 0 | -100,00 | ||||
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 640 | 101 145 | 1,65 | 81,56 | 133 750 | 8 248 880 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 478 | 99 505 | 1,51 | 78,12 | 115 454 | 7 772 833 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 478 | 98 027 | 1,53 | 71,33 | 105 426 | 6 992 266 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 478 | 96 549 | 1,55 | 59,24 | 87 549 | 5 719 080 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 040 | 95 071 | 1,11 | 49,48 | 51 454 | 4 703 638 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 375 | 94 031 | 4,88 | 40,22 | 175 962 | 3 781 927 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 081 | 89 656 | 2,38 | 36,68 | 76 321 | 3 288 134 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 081 | 87 575 | 2,43 | 34,70 | 72 211 | 3 038 852 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 040 | 85 494 | 1,23 | 36,46 | 37 924 | 3 117 539 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 562 | 84 454 | 1,88 | 36,96 | 57 732 | 3 121 420 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 430 | 82 892 | 0,52 | 25,76 | 11 079 | 2 135 712 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 333 | 82 462 | 6,91 | 29,75 | 158 657 | 2 453 244 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 860 | 77 129 | 1,13 | 28,94 | 24 888 | 2 232 113 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 430 | 76 269 | 0,57 | 26,17 | 11 253 | 1 995 960 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 148 | 75 839 | 0,20 | 30,74 | 4 550 | 2 331 291 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 478 | 75 691 | 1,99 | 74,30 | 109 815 | 5 623 841 | |
| 2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 573 | 74 213 | 0,78 | 27,28 | 15 629 | 2 024 160 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 434 | 13 302 | -25,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 434 | 13 302 | -25,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 434 | 13 302 | -25,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 434 | 19 216 | -18,75 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -3 122 | 11 508 | -21,34 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -3 122 | 11 508 | -21,34 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -13 125 | 21 875 | -37,50 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6 243 | 10 407 | -37,50 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6 243 | 10 407 | -37,50 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 688 | 9 852 | -32,24 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 290 | 430 | -75,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 290 | 430 | -75,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -41 335 | 5 333 | -88,57 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 580 | 860 | -75,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -444 | 148 | -75,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 719 | 573 | -75,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 922 | 14 764 | -25,00 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -13 666 | 73 640 | -15,65 | 118,75 | -1 622 838 | 8 744 750 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 30 404 | 87 306 | 53,43 | ||||
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -117 099 | 56 902 | -67,30 | 120,68 | -14 131 156 | 6 866 763 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 434 | 174 001 | 2,61 | 78,12 | 346 362 | 13 592 088 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 434 | 169 567 | 2,69 | 71,33 | 316 277 | 12 095 214 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 434 | 165 133 | 2,76 | 59,24 | 262 648 | 9 781 653 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 122 | 160 699 | 1,98 | 49,48 | 154 461 | 7 950 583 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 13 125 | 157 577 | 9,09 | 40,22 | 527 888 | 6 337 747 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 243 | 144 452 | 4,52 | 36,68 | 228 962 | 5 297 777 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 243 | 138 209 | 4,73 | 34,70 | 216 632 | 4 795 852 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 122 | 131 966 | 2,42 | 36,46 | 113 844 | 4 812 140 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 688 | 128 844 | 3,78 | 36,96 | 173 268 | 4 762 074 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 290 | 124 156 | 1,05 | 25,76 | 33 237 | 3 198 879 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 41 335 | 122 866 | 50,70 | 29,75 | 1 229 716 | 3 655 264 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 580 | 81 531 | 3,27 | 28,94 | 74 665 | 2 359 507 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 290 | 78 951 | 1,66 | 26,17 | 33 759 | 2 066 148 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 444 | 77 661 | 0,58 | 30,74 | 13 649 | 2 387 299 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 719 | 77 217 | 2,28 | 27,28 | 46 886 | 2 106 094 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 434 | 75 498 | 6,24 | 74,30 | 329 446 | 5 609 501 | |
| 2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 922 | 71 064 | 7,44 | 81,56 | 401 414 | 5 795 625 | |
| 2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10 175 | 10 175 | |||||
| 2014-12-23 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4 550 | 4 550 | |||||
| 2014-12-23 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 15 670 | 15 670 | |||||
| 2014-10-29 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10 175 | 10 175 | |||||
| 2014-07-29 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4 200 | 4 200 | |||||
| 2014-07-29 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 20 350 | 20 350 | |||||
| 2014-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -6 837 | 33 071 | -17,13 | 160,54 | -1 097 612 | 5 309 218 | |
| 2014-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 15 188 | 39 908 | 61,44 | ||||
| 2014-02-05 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 825 | 11 825 | |||||
| 2013-12-31 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -7 777 | 0 | -100,00 | ||||
| 2013-12-31 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -3 501 | 24 720 | -12,41 | 168,93 | -591 424 | 4 175 950 | |
| 2013-12-31 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 777 | 28 221 | 38,04 | ||||
| 2013-12-04 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3 280 | 3 280 | |||||
| 2013-12-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
| 2013-11-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2013-11-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -4 502 | 20 444 | -18,05 | 151,30 | -681 175 | 3 093 279 | |
| 2013-11-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 10 000 | 24 946 | 66,91 | ||||
| 2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 825 | 11 825 | |||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7 500 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7 500 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -5 000 | 14 946 | -25,07 | 146,47 | -732 335 | 2 189 096 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 500 | 19 946 | 60,26 | 62,35 | 467 625 | 1 243 633 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 500 | 12 446 | 151,64 | 70,63 | 529 725 | 879 061 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 081 | 6 244 | -25,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -3 125 | 7 270 | -30,06 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 718 | 860 | -66,64 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 718 | 860 | -66,64 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -23 333 | 23 334 | -50,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 577 | 860 | -74,98 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 577 | 860 | -74,98 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -3 438 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -3 438 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -3 437 | 1 146 | -74,99 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 583 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -17 787 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 500 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5 000 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5 000 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 392 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 219 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 875 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -3 657 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -1 393 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -558 | 0 | -100,00 | ||||
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -96 406 | 4 946 | -95,12 | 147,01 | -14 172 646 | 727 111 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 081 | 101 352 | 2,10 | 72,93 | 151 767 | 7 391 601 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 125 | 99 271 | 3,25 | 73,92 | 231 000 | 7 338 112 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 718 | 96 146 | 1,82 | 51,53 | 88 529 | 4 954 403 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 23 333 | 94 428 | 32,82 | 59,50 | 1 388 314 | 5 618 466 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 718 | 71 095 | 2,48 | 57,88 | 99 438 | 4 114 979 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 577 | 69 377 | 3,86 | 52,34 | 134 880 | 3 631 192 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 577 | 66 800 | 4,01 | 61,48 | 158 434 | 4 106 864 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 438 | 64 223 | 5,66 | 56,99 | 195 932 | 3 660 069 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 437 | 60 785 | 5,99 | 54,55 | 187 488 | 3 315 822 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 583 | 57 348 | 8,69 | 46,02 | 210 910 | 2 639 155 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 438 | 52 765 | 6,97 | 39,01 | 134 116 | 2 058 363 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 17 787 | 49 327 | 56,40 | 38,47 | 684 266 | 1 897 610 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 500 | 31 540 | 8,61 | 50,36 | 125 900 | 1 588 354 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 000 | 29 040 | 20,80 | 57,80 | 289 000 | 1 678 512 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 000 | 24 040 | 26,26 | 71,82 | 359 100 | 1 726 553 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 392 | 19 040 | 14,37 | 62,42 | 149 309 | 1 188 477 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 219 | 16 648 | 7,90 | 49,61 | 60 475 | 825 907 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 875 | 15 429 | 46,19 | 73,55 | 358 556 | 1 134 803 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 657 | 10 554 | 53,02 | 58,53 | 214 044 | 617 726 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 393 | 6 897 | 25,31 | 58,04 | 80 850 | 400 302 | |
| 2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 558 | 5 504 | 11,28 | 54,85 | 30 606 | 301 894 | |
| 2013-07-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 825 | 11 825 | |||||
| 2013-05-01 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 500 | 5 500 | |||||
| 2013-05-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 825 | 11 825 | |||||
| 2013-04-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -4 583 | 0 | -100,00 | ||||
| 2013-04-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -1 791 | 4 946 | -26,58 | 123,00 | -220 293 | 608 358 | |
| 2013-04-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 583 | 6 737 | 212,77 | ||||
| 2013-01-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 325 | 8 325 | |||||
| 2012-12-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 835 | 5 835 | |||||
| 2012-12-19 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
| 2012-11-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (Right to Buy) |
A - Award | 8 325 | 8 325 | |||||
| 2012-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 325 | 8 325 | |||||
| 2012-05-01 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 600 | 5 600 | |||||
| 2012-05-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 325 | 8 325 | |||||
| 2012-04-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -3 056 | 0 | -100,00 | ||||
| 2012-04-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -902 | 2 154 | -29,52 | 78,32 | -70 645 | 168 701 | |
| 2012-04-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 056 | 3 056 | |||||
| 2012-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Units |
A - Award | 4 167 | 4 167 | |||||
| 2012-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Stock options (right to buy) |
A - Award | 12 500 | 12 500 | |||||
| 2012-02-24 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
2 409 |
